financetom
Business
financetom
/
Business
/
What's Going On With Arm Holdings Stock Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Arm Holdings Stock Wednesday?
Jul 17, 2024 6:51 AM

Arm Holdings Plc ( ARM ) shares are trading lower Wednesday alongside several semiconductor stocks following soft guidance from ASML ( ASML ).

What Happened With ASML: ASML Holding N.V. ( ASML ) reported second-quarter sales of €6.242 billion ($6.82 billion), which beat analyst estimates of €6.032 billion, according to Benzinga Pro. The company reported second-quarter earnings of €4.01 per share, which beat analyst estimates of €3.71 per share.

Despite beating analyst estimates on the top and bottom lines, ASML ( ASML ) issued weak guidance for the third quarter. The company said it expects third-quarter net sales of €6.7 billion to €7.3 billion versus estimates of €7.608 billion. ASML ( ASML ) also guided for third-quarter gross margin between 50% and 51%.

“We see 2024 as a transition year with continued investments in both capacity ramp and technology. We currently see strong developments in AI, driving most of the industry recovery and growth, ahead of other market segments,” said Christophe Fouquet, president and CEO of ASML ( ASML ).

Why It Matters: Arm Holdings ( ARM ) is due to report financial results for its fiscal first quarter on July 31. The company is expected to report earnings of 34 cents per share and revenue of $903.573 million, according to estimates from Benzinga Pro.

Last quarter, Arm beat analyst estimates on the top and bottom lines and introduced guidance for fiscal year 2025. The company noted at the time that it had strong tailwinds heading into the year driven by increased demand for Arm-based technology “across all end markets.”

“From cloud to edge, all AI software models, from GPT to Llama, rely and run on the Arm compute platform. As these models become larger and smarter, their requirements for more compute with greater power efficiency can only be realized through Arm,” CEO Rene Haas said.

See Also: Why Key Apple, Nvidia Supplier TSMC’s Shares Are Plunging

ARM Price Action: Arm shares were down 4.30% at $171.09 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved